Global Keloid Treatment Market size was valued US$ XX Bn. in 2019 and the total revenue is expected to grow at 5.3% from 2019 to 2027, reaching nearly US$ XX Bn.
Global Keloid Treatment Market
The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
Keloid treatment contains corticosteroid injections or intraregional steroids in which they are good but quite pain-causing. Laser treatment of keloid includes the pulsed type dye laser that can be good at flattening the keloids & appearing them little less red.
The MMR report contains a detailed study of factors that will drive and restrain the growth of the keloid treatment market. Such as, the upsurge in expenditure on personal care products significantly contributes towards the development of the keloid treatment market globally. Keloids can appear anywhere on the body and affect an expected 10-15% of all wounds. According to the National Institute of Health, Keloid scars are most common in people with the age group of 10 years to 30 years. Keloid scars are usually seen in Asians, African Americans, or Hispanic descents. Expanding awareness regarding appearance and looks among people is the major fueling factor for the global keloid treatment market.
The availability of technologically advanced products like laser instruments, at lower costs is expected to boost their adoption, coupled with a significant presence of target population in the APAC is driving market expansion. Such as, there are more than 10 million cases each year in India only. As per the WHO (World Health Organization), in India, above 1,000,000 people are moderately burnt yearly.
Companies in the global keloid treatment market are more focused on enhancing their product and service offerings through many strategic approaches. Such as, in 2019, Xstrahl Medical, one of the major companies in superficial radiotherapy devices to treat dermatological conditions and, launched its newest superficial radiotherapy treatment system.
The MMR report will provide an accurate prediction of the contribution of the various segments to the growth of the keloid treatment market size. By end-user, the hospitals segment was valued at US$ XX.24 Mn in 2019 and is expected to reach US$ XX.43 Mn by 2027 at a CAGR of XX.34% during the forecast period. This is because of high patient footfalls in the hospitals for any treatment as hospitals are highly preferred over other treatment centers.
North America is expected to continue to hold the largest XX.76% share in keloid treatment market because of the high prevalence skin-related disorders and trauma coupled with the relatively high and easy availability as well as the adoption of new technologies, products, and treatment alternatives. For example, there are about 93 million people in the U.S. suffering from scars, out of which about 169 million scars can be characterized as hypertrophic and keloid scars. Yearly, 1.1 million burn injuries need medical attention in the U.S.
The objective of the report is to present a comprehensive analysis of the Global Keloid Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Keloid Treatment Market dynamics, structure by analyzing the market segments and projects the Global Keloid Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Keloid Treatment Market make the report investor’s guide.
Scope of the Global Keloid Treatment Market
Global Keloid Treatment Market, by Treatment Type
• Occlusive dressing
• Compression therapy
• Radiation therapy
• Laser therapy
• Interferon therapy
• Intralesional corticosteroid injection
• Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
Global Keloid Treatment Market, by End User
• Dermatology clinics
• Ambulatory surgical centers
Global Keloid Treatment Market, by Region
• Asia Pacific
• North America
• South America
• Middle East & Africa
Key players operating in Global Keloid Treatment Market
• Revitol Corporation Inc.
• Xstrahl Medical
• GlaxoSmithKline plc.
• Bristol-Myers Squibb Company
• Sensus Healthcare, Inc
• Novartis AG, Renovo Group plc.
• Bausch Health
• Scarless Laboratories Inc.
• Galena Biopharma, Inc.
• RXi Pharmaceuticals, Inc.
• Avita Medical
• Perrigo Company
• Soliton, Inc
For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-keloid-treatment-market/65786/
This Report Is Submitted By :Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.